Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Medicare study evaluates impact of U.S. Hospital Readmissions Reduction Program

Key clinical point: The U.S. Hospital Readmissions Reduction Program did not lead to harm through inappropriate triage of patients at high risk to observation units and the emergency department.

Major finding: Between 2008 and 2016, risk adjusted mortality increased annually by 0.05% only for heart failure, while it decreased by 0.06% for acute MI, and did not significantly change for pneumonia.

Study details: A retrospective cohort study of Medicare claims data from 2008 to 2016.

Disclosures: Dr. Khera disclosed that he is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health. His coauthors reported having numerous disclosures.


Khera et al. BMJ 2020 Jan. 15; doi:10.1136/bmj.l6831.